npj Precision Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2025-04-02 ms8000000052113185 来自上海

偏重的研究方向：肿瘤;癌症
经验分享：不是一般的慢

16 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2025-05-14 ms2000001485045977 来自浙江省

偏重的研究方向：肿瘤
经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧

9 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2025-03-11 ms4000002122050356 来自德国

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;深度学习
经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天

15 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2024-11-06 NGDZTPBCG 来自上海

偏重的研究方向：肿瘤;深度学习
经验分享：Technical check一般要多久呀？第五天了还是这个状态

40 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2023-10-28 ms8000001158768998 来自安徽省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：人工智能;临床预测
经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。

139 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2025-03-07 ms7000001515004055 来自安徽省

很慢很慢

16 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2024-12-21 ms8000000212980866

精彩评论，需要您登录查看

28 1 举报

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2024-08-17 ms1000001370318759 来自浙江省

manuscript under consideration 要多久啊

94 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2024-04-20 ms7000000021550557 来自上海

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;人工智能;肿瘤成像
经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。

127 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258778, encodeId=3c952258e7838, content=偏重的研究方向：肿瘤;癌症 经验分享：不是一般的慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cafb8445532, createdName=ms8000000052113185, createdTime=Wed Apr 02 10:15:59 CST 2025, time=2025-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2264991, encodeId=29462264991b0, content=偏重的研究方向：肿瘤 经验分享：像不在运营的感觉，非常的慢，编辑分配大概得2个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075a9469484, createdName=ms2000001485045977, createdTime=Wed May 14 11:59:09 CST 2025, time=2025-05-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2255554, encodeId=70be225555482, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;深度学习 经验分享：速度很慢，2024.07.30投稿，三轮修改后2025.03.07接收，历时7个月零7天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1115529261, createdName=ms4000002122050356, createdTime=Tue Mar 11 06:12:19 CST 2025, time=2025-03-11, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2235486, encodeId=54812235486ce, content=偏重的研究方向：肿瘤;深度学习 经验分享：Technical check一般要多久呀？第五天了还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Wed Nov 06 11:43:24 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2254978, encodeId=756822549e856, content=很慢很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb689654843, createdName=ms7000001515004055, createdTime=Fri Mar 07 09:39:15 CST 2025, time=2025-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243982, encodeId=2e64224398272, content=这个状态是啥意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/bb0bf9a716334c16a140b857fb88432d-9JtAZgM3zvMZ.jpg, type=image, width=1260, height=2720)], authenticateStatus=null, createdAvatar=null, createdBy=2c078098854, createdName=ms8000000212980866, createdTime=Sat Dec 21 08:47:15 CST 2024, time=2024-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2220744, encodeId=9c8f2220e4446, content=manuscript under consideration 要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9875545029, createdName=ms1000001370318759, createdTime=Sat Aug 17 11:58:32 CST 2024, time=2024-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199465, encodeId=6f642199465b2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;人工智能;肿瘤成像 经验分享：投出后第四天收到主编邮件分配副编辑，副编辑看完后当天送审，目前已经两周过去了，煎熬。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Sat Apr 20 16:36:38 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222605, encodeId=281e222260563, content=修回以后的Manuscript Under Consideration一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5c5721317, createdName=ms7000000021550557, createdTime=Tue Aug 27 09:02:55 CST 2024, time=2024-08-27, status=1, ipAttribution=上海)]

2024-08-27 ms7000000021550557 来自上海

修回以后的Manuscript Under Consideration一般要多久呀？

63 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务